UK markets closed

Vericel Corporation (VCEL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
48.50-0.91 (-1.84%)
At close: 04:00PM EDT
50.88 +2.38 (+4.91%)
After hours: 06:22PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close49.41
Open49.61
Bid48.47 x 100
Ask48.67 x 100
Day's range48.07 - 50.24
52-week range30.18 - 53.05
Volume278,190
Avg. volume371,450
Market cap2.357B
Beta (5Y monthly)1.70
PE ratio (TTM)4,850.00
EPS (TTM)0.01
Earnings date31 Jul 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est55.43
  • Insider Monkey

    Should You Consider Adding Vericel Corporation (VCEL) to Your Portfolio?

    Next Century Growth Investors, LLC, an investment Management Company, released its “Small Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. The market continued its rally in the first quarter of 2024; it paused in January but resumed its upward trajectory in February and March. In the quarter the small-cap […]

  • Insider Monkey

    Factors Behind Vericel Corporation (VCEL) Stock’s Positive Momentum

    Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Small Company Fund returned 0.48%, significantly underperforming the Russell 2000 Growth index’s 7.58% return. Following the release of the inflation report in February, the […]

  • GlobeNewswire

    Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

    CAMBRIDGE, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, and Joe Mara, CFO, will participate in a fireside chat at the Truist Securities MedTech Conference at 2:30 p.m. ET on Tuesday, June 18, 2024. A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://in